Rinella ME - Search Results

1

Aldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial.

Harrison SA, Abdelmalek MF, Neff G, Gunn N, Guy CD, Alkhouri N, Bashir MR, Freilich B, Kohli A, Khazanchi A, Sheikh MY, Leibowitz M, Rinella ME, Siddiqui MS, Kipnes M, Moussa SE, Younes ZH, Bansal M, Baum SJ, Borg B, Ruane PJ, Thuluvath PJ, Gottwald M, Khan M, Chen C, Melchor-Khan L, Chang W, DePaoli AM, Ling L, Lieu HD. Harrison SA, et al. Among authors: rinella me. Lancet Gastroenterol Hepatol. 2022 Jul;7(7):603-616. doi: 10.1016/S2468-1253(22)00017-6. Epub 2022 Mar 21. Lancet Gastroenterol Hepatol. 2022. PMID: 35325622 Clinical Trial.

2

Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial.

Van Wagner LB, Koppe SW, Brunt EM, Gottstein J, Gardikiotes K, Green RM, Rinella ME. Van Wagner LB, et al. Among authors: rinella me. Ann Hepatol. 2011 Jul-Sep;10(3):277-86. Ann Hepatol. 2011. PMID: 21677329 Free article. Clinical Trial.

3

Dysregulation of the unfolded protein response in db/db mice with diet-induced steatohepatitis.

Rinella ME, Siddiqui MS, Gardikiotes K, Gottstein J, Elias M, Green RM. Rinella ME, et al. Hepatology. 2011 Nov;54(5):1600-9. doi: 10.1002/hep.24553. Epub 2011 Jul 27. Hepatology. 2011. PMID: 21748768 Free PMC article.

4

Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events.

Vanwagner LB, Bhave M, Te HS, Feinglass J, Alvarez L, Rinella ME. Vanwagner LB, et al. Among authors: rinella me. Hepatology. 2012 Nov;56(5):1741-50. doi: 10.1002/hep.25855. Hepatology. 2012. PMID: 22611040

5

Controversies in the Diagnosis and Management of NAFLD and NASH.

Rinella ME, Loomba R, Caldwell SH, Kowdley K, Charlton M, Tetri B, Harrison SA. Rinella ME, et al. Gastroenterol Hepatol (N Y). 2014 Apr;10(4):219-27. Gastroenterol Hepatol (N Y). 2014. PMID: 24976805 Free PMC article.

6

The "dose" of exercise and its effects beyond weight loss.

Rinella ME. Rinella ME. Hepatology. 2015 Apr;61(4):1115-7. doi: 10.1002/hep.27669. Epub 2015 Mar 10. Hepatology. 2015. PMID: 25546322 No abstract available.

7

NAFLD in 2014: Genetics, diagnostics and therapeutic advances in NAFLD.

Rinella ME, Sanyal AJ. Rinella ME, et al. Nat Rev Gastroenterol Hepatol. 2015 Feb;12(2):65-6. doi: 10.1038/nrgastro.2014.232. Epub 2015 Jan 6. Nat Rev Gastroenterol Hepatol. 2015. PMID: 25560844 Free PMC article. Review.

8

Screening for nonalcoholic fatty liver disease in patients with atherosclerotic coronary disease?--In principle yes, in practice not yet.

Rinella ME. Rinella ME. Hepatology. 2016 Mar;63(3):688-90. doi: 10.1002/hep.28341. Epub 2016 Jan 8. Hepatology. 2016. PMID: 26566595 No abstract available.

9

Practice patterns in NAFLD and NASH: real life differs from published guidelines.

Rinella ME, Lominadze Z, Loomba R, Charlton M, Neuschwander-Tetri BA, Caldwell SH, Kowdley K, Harrison SA. Rinella ME, et al. Therap Adv Gastroenterol. 2016 Jan;9(1):4-12. doi: 10.1177/1756283X15611581. Therap Adv Gastroenterol. 2016. PMID: 26770262 Free PMC article.

10

Management of NAFLD: a stage-based approach.

Rinella ME, Sanyal AJ. Rinella ME, et al. Nat Rev Gastroenterol Hepatol. 2016 Apr;13(4):196-205. doi: 10.1038/nrgastro.2016.3. Epub 2016 Feb 24. Nat Rev Gastroenterol Hepatol. 2016. PMID: 26907882 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page